633 results on '"Kaira, K"'
Search Results
2. Unexpected response of extramedullary plasmacytoma in patients with lung cancer who received nivolumab
3. Epiregulin as a therapeutic target in non-small-cell lung cancer
4. 1078P Correlation between T cell immunity and EGFR-TKI treatment in patients harboring EGFR driver mutation
5. 1067P Discovery of a new CD4+ T cell cluster that correlates PD-1 blockade efficacy
6. Endoplasmic reticulum stress in the pathogenesis of pretibial dystrophic epidermolysis bullosa
7. Efficacy of platinum combination chemotherapy after first-line gefitinib treatment in non-small cell lung cancer patients harboring sensitive EGFR mutations
8. 1292MO A phase II study of daily carboplatin plus irradiation followed by durvalumab for unresectable III non-small cell lung cancer patients with PS 2 or elderly (≧75 years): NEJ039A
9. Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer
10. Detection of human papillomavirus (HPV) in patients with squamous cell carcinoma and the clinical characteristics of HPV-positive cases
11. 411P Impact of pre-treatment AXL expression on osimertinib efficacy in patients with non-small cell lung cancer with EGFR mutation
12. Phase II trial of carboplatin, nab-paclitaxel and bevacizumab for advanced non-squamous non-small cell lung cancer (CARNAVAL study; TORG1424/OLCSG1402)
13. P1.04-34 Efficacy and Safety of First-Line Pembrolizumab Monotherapy in Elderly Patients (Aged ≥ 75 years) with Non-Small Cell Lung Cancer
14. Effector CD4+ T-cell induction by thoracic radiotherapy for patients with NSCLC
15. EP1.01-83 Efficacy and Safety of EGFR-TKI Rechallenge Treatment in Elderly Patients with Advanced NSCLC Harboring Sensitive EGFR Mutations
16. Pseudomesotheliomatous adenocarcinoma of the lung with synchronous gastric and esophageal cancer
17. Hepatobiliary and pancreatic: Multifocal nodular hepatic steatosis associated with the metabolic syndrome
18. Expectoration of bronchogenic tumour tissue
19. IMAGES IN EMERGENCY MEDICINE
20. Pulmonary adenocarcinoma presenting as a giant pleural mass
21. Abstract PD4-08: Relationship between FDG-uptake and expression level of PD-L1 in primary ER positive/HER2 negative breast cancer
22. P1.01-92 A Phase II Study of Afatinib Treatment for Elderly Patients with Previously Untreated Advanced NSCLC Harboring EGFR Mutations
23. P3.01-111 Efficacy and Safety of Cytotoxic Drug Chemotherapy After First-Line EGFR-TKI in Elderly Patients with NSCLC Harboring Sensitive EGFR Mutations
24. P3.01-43 Predictive Value of Computed Tomography Characteristics for Nivolumab Response in Pretreated Non-Small Cell Lung Cancer
25. P2.01-027 Clinical Significance of Topoisomerase-II Expression in Patients with Non-Small Cell Lung Cancer Treated with Amrubicin
26. A retrospective study of amrubicin monotherapy for the treatment of relapsed small cell lung cancer in elderly patients
27. P2.15-016 Clinical Significance of Topoisomerase-II Expression in Patients with Relapsed HGNEC of the Lung Treated with Amrubicin
28. P1.15-002 A Retrospective Study of Amrubicin Monotherapy for the Treatment of Relapsed Small Cell Lung Cancer in Elderly Patients
29. P2.15-005 Post-Progression Survival Is Strongly Linked to Overall Survival in Refractory Small-Cell Lung Cancer Patients Who Received Amrubicin
30. P2.02-026 Impact of PD-L1 Expression on 18F-FDG-PET in Pulmonary Squamous Cell Carcinoma
31. 511P - Phase II trial of carboplatin, nab-paclitaxel and bevacizumab for advanced non-squamous non-small cell lung cancer (CARNAVAL study; TORG1424/OLCSG1402)
32. 1468P - Effector CD4+ T-cell induction by thoracic radiotherapy for patients with NSCLC
33. Prognostic impact of LAT1 and CD98 expression in cutaneous angiosarcoma
34. Expression of thymidylate synthase (TS) and its prognostic significance in patients with cutaneous angiosarcoma
35. 460P Phase I/II trial of carboplatin, nab-paclitaxel and bevacizumab for advanced non-squamous non-small cell lung cancer (CARNAVAL; TORG1424/OLCSG1402): results of the phase I part
36. Prognostic significance of thymidylate synthase (TS) expression in cutaneous malignant melanoma
37. Prognostic significance of GRP78/BiP expression in patients with Stage III/IV hypopharyngeal squamous cell carcinoma
38. Expression of ER stress markers (GRP78/BiP and PERK) in patients with tongue cancer
39. 497P - A retrospective study of amrubicin monotherapy for the treatment of relapsed small cell lung cancer in elderly patients
40. Recurrent intimal sarcoma mimicking pulmonary embolism
41. Images in emergency medicine. Crohn's disease
42. P0143 ASC amino acid transporter 2 (ASCT2) as a novel prognostic marker in non-small-cell lung cancer
43. Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer
44. Biological significance of fluorine-18-α-methyltyrosine (FAMT) uptake on PET in patients with oesophageal cancer
45. ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer
46. Clinicopathological and prognostic significance of interleukin-8 expression and its relationship to KRAS mutation in lung adenocarcinoma
47. Psoas abscess as the presenting manifestation of Crohn's disease
48. A Randomized Phase II Study of Axitinib Plus Pemetrexed/Cisplatin (PEM/CIS) for Non-Small-Cell Lung Cancer (NSCLC)
49. Prognostic Significance of L-Type Amino Acid Transporter 1 Expression in Completely Resected Pancreatic Cancer
50. Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.